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A murine monoclonal antibody, designated K20, was raised 
by immunization with a human malignant T-cell line. It 
reacted specifically with membrane glycoprotein complexes 
on early haematopoietic cells, T cells, and monocytes. In 
epidermis, K20 specifically reacted with Langerhans cells 
and basal keratinocytes, as demonstrated by double labeling 
experiments. Membrane immunoprecipitation analysis dem- 
onstrated that the antigen identified by K20 on lymphoid 
cells and epidermal cells was different. While on lymphoid 
cells, K20 recognized glycoprotein complexes made of a 
constant 130-kD subunit associated with subunits of higher 
molecular weight ranging from 150 to 200 kD, a complex of 
105 - 145 kD was precipitated from Langerhans and basal 
t has recently been shown that different monoclonal antibod- 
ies (MoAb) supplied by the International Workshops and 
Conferences on Human Leucocyte Differentiation Anti- 
gens, react with various skin components such as Langerhans 
cells [ 1 - 31 and b asa or whole keratinocytes [4,5]. 1 
Among the MoAb we have tested on human skin sections, K20 
was shown to identify two different subpopulations of epidermal 
cells. It reacts with a membrane antigen and its expression is con- 
fined to basal layer keratinocytes and Langerhans cells (LC) of nor- 
mal skin. 
The MoAb K20 was produced following the immunization of 
Biozzi mice with cells from a human T-cell lymphoma. K20 identi- 
fies glycoprotein complexes in humans, which are preferentially 
expressed on early haematopoietic cells, monocytes and a subset of 
peripheral blood T cells, but not on peripheral blood B cells. These 
glycoprotein complexes are made of a constant 130-kD subunit 
non-covalently associated at the cell surface with subunits of higher 
Molecular Weight (MW) (160 kD, 200 kD) and with subunits of 
85 and 70 kD. Further characterization of this MoAb was reported 
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cells. Metabolic labeling studies demonstrated that these pro- 
teins were synthesized by the basal cells. The antigen identi- 
fied by K20 was thought to belong to the integrins, a family 
of cell surface receptors that play a role in cell adhesion, cell 
interactions, wound healing, and immune defense mecha- 
nisms. 
K20 is the first monoclonal antibody that specifically rec- 
ognizes a membrane antigen common to Langerhans and 
basal cells. Additionally, K20 is the first of five reported 
monoclonal antibodies to have been characterized on the 
epidermal cells that detect antigens shared by lymphoid sub- 
populations and normal basal keratinocytes.] Invest Dermad 
92:739- 745, 1989 
in detail elsewhere [6] [CDw29 recognizes the common subunit of 
the VLA family: direct involvement in T-cell activation (unpub- 
lished)]. This antibody has been assigned to the CDw29 cluster of 
differentiation antigens [7]. 
K20 is one of five reported MoAb that detect antigens shared by 
lymphoid subpopulations and normal basal keratinocytes. HCl de- 
tects a membrane antigen expressed by hairy leukemia cells, endo- 
thelial cells, and basal keratinocytes [8]. MoAb 4F2 detects a mem- 
brane protein shared by lymphoid cell lines, monocytes, a subset of 
activated T cells, and basal keratinocytes [9,10]. EL-a was shown to 
be identical to the 4F2 MoAb [ 1 I], and EL+ demonstrates specific- 
ity for a membrane antigen shared by T and B lymphoblastoid cell 
lines, a subpopulation of immature lymphocytes in the thymus and 
bone marrow, proliferating fibroblasts, and epidermal basal kera- 
tinocytes [12]. All four antibodies were prepared by immunization 
with lymphoid cells. On these cells 4F2 and EL_, recognize a gly- 
coprotein complex (120 kD) made of two subunits (80 and 40 kD) 
[11,13]; EL_, recognizes a single protein of MW 105 kD, but the 
Molecular Weight of the antigen recognized by HCl is still un- 
known. The antigens recognized by these four MoAb on basal kera- 
tinocytes have not been characterized. 
We report here the characterization by immunoprecipitation 
analysis of the proteins recognized by K20 in epidermis. Our results 
show that the protein complex identified by K20 on LC and basal 
cells (BC) is similar but not identical to the one found on lymphoid 
cells. The identification of the antigen recognized by K20 as being a 
surface glycoprotein complex involved in cell adhesion is discussed. 
MATERIALS AND METHODS 
Antibodies The MoAb K20 (IgG2a) was kindly provided by Dr. 
Boumsell (INSERM U 93, Paris, France), through the exchanges of 
the Third International Workshop on Human Leucocyte Differen- 
tiation Antigens. 
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The MoAb MAS054 was obtained commercially (Sera-Lab). This 
rat MoAb recognizes a monomorphic determinant on the HLA-DR 
molecule on human cells. It reacts exclusively with LC among 
normal epidermal cells [ 141. 
Bullous pemphigoid polyclonal antibodies (Bp Pab) are known to 
specifically characterize basal keratinocytes. Human serum obtained 
from a patient with active BP and giving a positive immunofluores- 
cence reaction with the basement membrane zone of normal skin 
(titer 1 : 1000) was used. 
Epidermal Cell Suspensions Cell suspensions were obtained by 
trypsinization of human normal skin specimens taken during plastic 
surgery. Trimmed skin was split-cut with a keratotome set at 
0.1 mm. The resulting slices were immersed in a 0.25% solution of 
trypsin (Difco) in Hanks’ balanced salt medium (Gibco) for over- 
night incubation at 4°C. The epidermis was detached from the 
dermis with a fine forceps. The epidermal sheets were agitated in 
minimum essential medium (MEM; Gibco) supplemented with 
20% fetal calf serum (FCS). Th e resulting suspension was filtered 
through gauze and centrifuged for 10 min at 400 g. Following a 
double wash in MEM-FCS, the cells were counted and their viabil- 
ity assessed by trypan blue exclusion. Viability was 87% or higher. 
This epidermal cell suspension was then enriched in basal cells by 
utilizing the specific ability of these cells to adhere to collagen, as 
described elsewhere [15,16]. Viability of the recovered cells was 
95%. 
Langerhans cells enrichment was obtained by Ficoll-Hypaque 
(Pharmacia-France) sedimentation [13]. To improve the enrich- 
ment, a second sedimentation was performed on a Ficoll gradient, 
the density of which was decreased from 1.077 to 1.068. Viability 
was 95% or higher. 
Immunofluorescence Microscopy The LC- and basal-enriched 
epidermal suspensions were labeled with K20 at a 1: 200 dilution 
for 1 h, followed by fluorescein-conjugated F(ab’)a anti-mouse Ig 
(Zymed, Burlingame, CA) at a 1: 40 dilution for 30 min. This first 
indirect immunofluorescence using K20 and fluorescein-conju- 
gated Ig was followed by a second indirect immunofluorescence 
where antibodies were revealed with appropriate rhodamine-conju- 
gated F(ab’)a Ig (dilution 1: 40). LC were labeled in suspension with 
MAS054 MoAb (dilution 1: 800), and BC were labeled with BP Pab 
(dilution I : 500) after smearing on glass slides and air-drying. All 
incubations were performed in MEM supplemented with 5% FCS, 
Figure 1. Indirect immunofluorescence staining of human skin with K20. 
Basal keratinocytes stain positively in the epidermis (X250). Note the stain- 
ing of endothelial cells of papillary vessels (arrows). 
Figure 2. Double staining of BC and LC suspensions. a and b correspond to 
the same microscopic field of BC-enriched suspensions. Cells were stained 
in suspension with K20 (fluorescein) (a), then air-dried on glass slides and 
incubated with Bp Pab (rhodamine) (b). The cells labeled with K20 are 
positive for Bp antigen (X500). c and d correspond to the same microscopic 
field of LC-enriched suspensions. Cells were stained in suspension with K20 
(fluorescein) (c), and MAS054 (rhodamine) (d) (X500). LC were weakly 
stained with K20, while the staining with MAS054 was very strong. The 
appearance of a rather strong staining with K20 was explained by the strong 
labeling of MASO revealed by rhodamine conjugate, which yielded a 
yellowish flurorescent color when excited with the filter for fluorescein. 
The amnu points to a K20 positive-MAS054 negative cell, corresponding to 
a basal keratinocyte. 
and each incubation was followed by two washes in MEM. Fluores- 
cent cells were counted under a Zeiss Orthoplan microscope with 
selective excitation filters for fluorescein and rhodamine. 
Immunolabeling on Human Skin Samples of normal skin were 
snap-frozen in liquid nitrogen, embedded in Tissue-Tek (Miles), 
and cut at 4 pm sections. After air-drying, the sections were fixed in 
cold acetone for 5 min, washed in phosphate buffered saline, and 
then stained with K20 (dilution 1: 200) [5]. 
Fluorescence-Activated Cell Sorter Analysis Flow cytometry 
analysis was performed on a Cytofluorograph 50 H (Ortho Instru- 
ments). Rapidly, BC- and LC-enriched cell suspensions were incu- 
bated with K20 at a I : 200 dilution for 1 h, followed by washings 
and labeling with FITC-conjugated F(ab’)a GaM IgG (Zymed, Bur- 
lingame, CA). Mouse myeloma UPC10 Ig2a (Sigma, St. Louis, 
MO) was used at the same dilution as a negative isotype control. 
Fluorescence intensity log scale 
Figure 3. Cytofluorometric analysis of BC- and LC-enriched cell suspen- 
sions stained with K20. Distribution of cells is presented according to the 
number of cells (y-axis) and green fluorescence (x-axis). Histograms from 
K20-expressing LC and BC (identically stained samples) show that LC (a) 
demonstrate mean fluorescence channel of 85 and that BC (bj are brighter 
with mean fluorescence channel 140. The first peak of histogram b corre- 
sponds to negative keratinocytes and the second peak of histogram a corre- 
sponds to the BC contaminating the LC suspensions. 
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Figure 4. Lmmunogold labeling of LC-enriched suspensions with K20. II: 
At this magnification, gold particles, although hardly visible, decorate the 
cell surface of the LC (X10,000). b: Higher magnification (X57,000). Bg: 
Birbeck granules. 
Immunogold Labeling Procedure LC and BC suspensions 
were fixed by 2% paraformaldehyde in phosphate buffered saline. 
Cells were washed in Tris buffered saline-l% BSA and labeled using 
a previously described method [17]. K20 mouse IgG2a were re- 
vealed with 15 nm gold granule-conjugated goat anti-mouse IgG 
(Janssen, Pharmaceutics, Belgium). Cells were then post-fixed and 
prepared for electron microscope analysis [17]. As negative isotype 
control, labelings with mouse myeloma UPC10 Ig2a obtained from 
clarified ascites fluid (Sigma, St. Louis, MO) were performed. 
Radiolabeling and Immunoprecipitation Cells were exter- 
nally labeled with 1251 by using the glucose oxidase/lactoperoxidase 
technique [18]. Also, BC- and LC-enriched suspensions were meta- 
bolically labeled with 35S-methionine (100 @i/ml) for 18 h at 
37°C. Labeled cells were extracted with Tris buffered saline-l% 
NP40, and immunoprecipitation was carried out as recently de- 
scribed [19]. Th . e immunoprecipitates were washed, resuspended in 
sample buffer (with or without 5% 2-mercaptoethanol), and ap- 
plied to SDS-polyacrylamide slab gels. 
Enzymatic Digestion Endo F treatment, which cleaves N- 
linked carbohydrate, was carried out following immunoprecipita- 
tion from BC-enriched suspensions. After immune complexes were 
washed, the pellet was suspended in 50 ~1 of 50 mM EDTA, 0.5% 
NP40, 1% mercaptoethanol, 0.1 M sodium phosphate (pH 6.1). 
One unit ofEndo F (NEN Research Products) was added for 16 h at 
37°C; then 50 ~1 of SDS-sample buffer was added and gel electro- 
phoresis was carried out as follows. 
Gel Electrophoresis Electrophoresis was performed both on a 
7.5% acrylamide gel and on a linear gradient (5% - 15%) of acryla- 
mide by using Laemmli’s method [20]. Molecular weight standards 
were 14C-methylated proteins from Amersham. To reveal iodinated 
Figure 5. K20 immunogold labeling of basal keratinocytes. a: Numerous 
gold granules are scattered along the plasma membrane (X9,000). b: At 
higher magnification, the gold granules are clearly visible (X54,000). No 
gold granules were detected within the cytoplasm. KF: Keratin filaments; m: 
melanosomes. 
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antigens identified by K20, film exposure time was 5 d, while to 
reveal the antigens labeled with 35S-methionine, gels were subjected 
to fluorography by using Amplify (Amersham), and film exposure 
time was 2 d. 
Cell Line Epstein Barr virus (EBV) transformed B lymphocyte 
line (B 95.8) was kindly provided by Dr C. Desgranges (Lyon, 
France). 
RESULTS 
Immunolabelings 
On Human Skin: On frozen sections of normal skin, K20 bound to 
the basal layer keratinocytes. This was visualized as bright staining 
of the surface membrane on cells in the basal layer (Fig 1). LC were 
also stained with K20, but the staining intensity was very weak and 
LC were not visible on the photomicrographs. In the dermis, 
smooth muscle and vessel endothelial cells were positive with K20. 
On Cell Suspensions: The antigen recognized by K20 was trypsin 
resistant because cell staining obtained after trypsinization was pos- 
a 
b 
Pigure 6. Immunogold labeled basal cells. (I: This detail shows that the 
strong K20 immunogold labeling of the plasma membrane is not observed 
along the whole surface of the cell. Only a few gold granules could be seen 
on the surface where hemidesmosomes were observed. This side appears as 
the pole of the cell facing the basement membrane (X20,000). b: Higher 
magnification showing that the hemidesmosomes (arrow) are negative 
(X75,000). KF: Keratin filaments; m: melanosomes. 
Figure 7. Negative control. Cells were incubated with a mouse myeloma 
IgG2a obtained from clarified ascites fluid. a: Basal keratinocyte (X 9,000); b: 
Langerhans cell (X 9,000); Bg: Birbeck granules; KF: keratin filaments; nz: 
melanosomes. 
sible. Double labeling experiments provided confirmation that both 
epidermal LC and BC were specifically stained with K20. 
By utilizing the specific ability of BC to adhere to collagen, 
suspensions containing an average percent number of Bp antigen 
bearing cells of 80% + 10% were obtained. LC accounted for less 
than 1% in these suspensions. Most of the cells positive for Bp 
antigen exhibited a cap of red fluorescence confined to one pole of 
the cell and were also reactive with K20 as demonstrated by cell 
surface membrane fluorescence (Fig 2a,b). 
The number of LC was 2% - 4% before enrichment. In epidermal 
cell suspensions fractionated by two successive Ficoll-Hypaque sed- 
imentations, LC accounted for not less than 60%. In these suspen- 
sions, the number of BC did not exceed 8%, as checked by labeling 
with Bp serum. As already demonstrated, MASO (anti HLA-DR 
MoAb) and 0KT6 (specific for LC in epidermis) stain identical cells 
[14]. The cells labeled with MAS054 MoAb, identified as LC, were 
also weakly positive with K20 (Fig 2c,d). 
Cytofluorometric analysis showed that LC and BC were stained 
with K20 and confirmed that LC were less intensely labeled than 
BC (Fig 3). 
The use of a highly specific immunogold technique in electron 
microscopy allowed the K20 specificity to be defined more pre- 
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Figure 8. Comparison of the antigen recognized by K20 on LC, BC, and 
EBV-transformed B lymphocytes. Labeling with ia51, extraction and immu- 
noprecipitation were carried out as described in Materials and Methods. Gel 
analysis was performed on a linear gradient (5%- 15%) of acrylamide in the 
presence of 5% 2-mercaptoethanol. K20 was used to precipitate antigen 
from LC-enriched suspensions (lane a), BC-enriched suspensions (lane b), 
and EBV-transformed B lymphocytes (lane d) . Controls using normal mouse 
serum are from LC (lane c) and EBV-transformed B lymphocytes (lane e). 
Standards (St) are myosin (200 kD), phosphorylase b (92.5 kD), bovine 
serum albumin (69 kD), ovalbumin (46 kD), carbonic anhydrase (30 kD), 
and lysozyme (14.3 kD). 
cisely. The labeled cells were identified by the presence of gold 
granules distributed along the cell surface. Variable numbers of gold 
granules were observed according to the type of cell. The density of 
gold granules observed on LC (characterized by the presence of 
Birbeck granules in the cytoplasm) was low compared with that 
observed on basal keratinocytes (Figs 4 and 5). This observation 
affords an explanation for the very weak staining of LC observed on 
skin sections. In addition, the intensity of K20 labeling was variable 
along the BC membrane. The site of attachment of BC to the 
basement membrane zone, characterized by the presence of hemi- 
desmosomes, showed barely detectable gold granules in comparison 
with the rest of the cell membrane. Hemidesmosomes were nega- 
tive (Fig 6). A few gold g ranules were observed along the membrane 
of suprabasal spinous keratinocytes. No gold granules were ob- 
served on the cells when K20 was replaced by UPC10 IgG2a used as 
negative isotype control (Fig 7). 
The Antigen Complex Recognized by K20 on LC and BC 
The K20 antigen was immunoprecipitated from LC, BC, and EBV 
transformed B lymphocytes and was analyzed by polyacrylamide 
gel electrophoresis (PAGE). Under reducing conditions, K20 im- 
munoprecipitated, from externally labeled EBV-transformed B 
lymphocytes, a broad 130 kD protein band, and proteins of an ap- 
parent MW of 170,150, and 80 kD. A faintly visible band of 90 kD 
was also observed (Fig 8). These results are in agreement with those 
obtained when precipitation was carried out on lysates of various 
externally labeled leukocyte cells [6]. On the contrary, immunopre- 
cipitation of 1251-labeled LC and BC gave different protein bands. 
K20 precipitated a broad 105 kD band and proteins of 145,90, and 
80 kD. These proteins were precipitated both from human LC- and 
BC-enriched suspensions (Fig 8). The bands observed in lunea in Fig 
8 represent K20 immunoprecipitated from lysates of suspensions 
containing not less than 60% LC and no more than 8% BC. A band 
of approximately 40 kD was precipitated from BC-enriched sus- 
pensions only. Controls were carried out on the same gels. 
Under non-reducing conditions, each band immunoprecipitated 
by K20 was shifted down by approximately 5000 MW (results not 
shown). The lower mobilities of polypeptides in the absence of 
reduction are consistent with the presence of intrachain disulfide 
bridges within each unit. 
Further, in order to determine whether the proteins precipitated 
by K20 were endogenously biosynthesized, immunoprecipitation 
of 35S-methionine labeled lysates obtained from overnight labeled 
BC- and LC-enriched suspensions was performed. The results 
showed that the 145- and 105-kD protein bands were synthesized 
by BC, but the 105-kD band was only faintly visible in comparison 
with that precipitated from the cell surface (Fig 9). No bands were 
precipitated when metabolic labeling of LC was carried out (data 
not shown). 
To determine the carbohydrate content of each subunit immuno- 
precipitated from BC-enriched suspensions, digestion with Endo F 
was carried out. The removal of N-linked glycans resulted in a 
decrease of approximately 15 kD for each band compared to the 
untreated subunits (Fig 10). 
DISCUSSION 
A MoAb, K20, raised against a human T-cell lymphoma, was found 
to react strongly with human epidermal LC and BC. Four different 
MoAb prepared against lymphoid cells have already been reported 
to react with basal keratinocytes. The proteins recognized by these 
Figure 9. SDS-PAGE analysis of immunoprecipitate from lysate of?S-me- 
thionine labeled BC. BC were labeled for 18 h with s5S-methionine. Using 
the same conditions as in Fig 8, K20 immunoprecipitate was run in lone c. 
The 145 and IO5 kD proteins (asrerirk) were synthesized by BC. Compared 
with ‘asI surface labeling, 35S-methionine metabolic labeling inevitably re- 
sults in an increased number of labeled nonspecific background bands. The 
results of control immunoprecipitations that show all the background bands 
are included in lanes a (normal mouse serum) and b (a negative control 
MoAb). St: standards. 
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Figure 10. Endo F treatment of immunoprecipitated proteins from BC- 
enriched suspensions. Immunoprecipitated proteins were treated with 0 
(minus sign) or 1 unit (plus sign) ofEndo F. The removal of N-linked glycans 
resulted in a decrease of approximately 15 kD for each band compared to the 
untreated subunits (open star: 145 kD; closed star: 105 kD; open circle: 90 kD; 
arrowhead: 80 kD). 
MoAb have been characterized from T-cell lines but not from basal 
cells. The aim of this study was to determine the antigen recognized 
by K20 on epidermal cells. 
First, we have demonstrated by indirect immunofluorescence 
studies the presence of a surface membrane antigen, reactive with 
K20, which is confined to the LC and the basal layer keratinocytes 
of normal epidermis. Double labeling experiments carried out with 
MoAb and Pab specific for LC (MAS054) and BC (Bp Pab) allowed 
the reactivity of K20 with these two different types of epidermal 
cells to be confirmed. A difference between LC and BC, with regard 
to the density of the antigenic sites recognized by K20 on the surface 
membrane, could be demonstrated by electron microscope studies. 
The K20 receptors were evenly distributed on the LC membrane 
and were far fewer in number than those observed on the BC mem- 
brane. On the contrary, the distribution of the antigen along the cell 
surface of BC was discontinuous. Numerous gold granules were 
uniformly distributed along the cell membrane except on one side, 
which was characterized as the side facing the basement membrane 
due to the presence of numerous hemidesmosomes (negative with 
K20). This suggests that the K20 antigen is poorly expressed on the 
dermal side of the basal cell membrane. 
In order to establish the identity of the antigen recognized by 
K20, immunoprecipitation analysis was performed using radioio- 
dinated membrane extracts of LC and BC. The results showed that 
K20 recognized a protein complex composed of a prominent 105- 
kD subunit, one protein of higher MW (145 kD), and two proteins 
of lower MW (90 and 80 kD). An identical protein complex was 
recognized by K20 on both types of cells. Surprisingly, these bands 
were different in size from those precipitated by K20 from lysates of 
radioiodinated EBV-transformed B lymphocytes which corre- 
sponded to a complex made up of a broad band of 130 kD associated 
with proteins of 170, 150, 90, and 80 kD. This latter result fits in 
with those obtained from radioiodinated non-epidermal cell types 
where glycoprotein complexes with a constant 130 kD subunit 
non-covalently associated with subunits of higher MW (170, 
150 kD) and also with a lower (80 kD) subunit were observed [6]. 
It can be noted that an additional band of approximately 40 kD 
was precipitated from BC only. Internal labeling studies using BC 
extracts demonstrated that the 145 and 105 kD proteins were syn- 
thesized by the cells and not merely taken from the extracellular 
environment. K20-recognized proteins could not be immunopre- 
cipitated from biosynthetically labeled LC suspensions. Whether 
LC are passive carriers of these proteins or whether LC are really 
able to synthesize these proteins remains difficult to prove. Indeed, 
the synthesis of the T6 antigen, which is considered a highly spe- 
cific marker of LC, has not yet been demonstrated from LC or 
thymocytes [21]. LC are known to be a rather slow-cycling-cell 
population [22] and robably have a low metabolic turnover. That 
could explain the dr .d culties in demonstrating protein biosynthesis 
in LC. 
Similar but not identical sets of proteins were immunoprecipi- 
tated by K20 from lymphoid and epidermal cells. Differences were 
noted with regard to the molecular weight of the different subunits 
immunoprecipitated. The biologic function of the membrane pro- 
tein recognized by K20 on LC and BC can only be speculated upon. 
Nevertheless, it has been demonstrated that K20 and A-IA5 precip- 
itate similar protein complexes from lymphoid cells [6,23]. A-IA5 
recognizes the VLA (very late activation) antigen complexes which 
were first characterized as very late appearing antigens on in vitro 
cultured T lymphocytes [24,25]. There are at least five distinct 
heterodimers in the VLA protein family, each composed of a unique 
(Y subunit associated with a common /3 subunit [23-261. It has 
recently been confirmed that K20 recognizes the common/3subunit 
of all VLA proteins [23,27]. It is now clear that nearly all tissues and 
cell types express one or more VLA complexes [28]. K20 appears, 
therefore, to demonstrate the presence of proteins of the VLA fam- 
ily on epidermal cells. 
The protein complex evidenced on epidermal cells is made of 
glycoproteins, because each subunit was shown to be sensitive to the 
Endo F treatment, which cleaves N-linked carbohydrate. The re- 
moval of N-linked glycans (after addition of 1 unit of Endo F) 
resulted in a decrease of approximately 15 kD in the apparent MW 
of each subunit. Similar results were obtained when the VLA-1 and 
VLA-2 glycoprotein complexes, observed on long-term PHA-stim- 
ulated T cells, were submitted to the Endo F treatment [25]. The 
glycoprotein complexes evidenced on epidermal cells behave like 
the VLA proteins described on T-cell lines. 
The VLA complexes belong to a superfamily of related cell sur- 
face adhesive receptors which also includes the fibronectin receptor, 
the vitronectin receptor, the platelet membrane glycoprotein IIb - 
IIIa corn lex, and the LFA-1, Mac-l, p150,95 antigens on leuko- 
cytes [29 P . These receptors, termed integrins by Hynes [29], consist 
of two noncovalently linked (Y and /I subunits. These proteins are 
involved in various forms of adhesion reactions, and it has recently 
been claimed that the VLA antigens may be involved in extracellu- 
lar matrix adhesion functions. VLA-2 is identified as a collagen 
receptor, VLA-5 as a fibronectin receptor, and VLA-3 appears to 
have multiple ligands (fibronectin, laminin, collagen)[27,30,31]. 
Our data provide evidence that adhesive protein receptors of the 
VLA family are present on two subpopulations of epidermal cells, 
and further analyses are in progress to determine the role of the 
molecules recognized by K20 on LC and BC. 
Further, an immunologic role of the protein complex recognized 
by K20 has been demonstrated: K20 inhibits CD3-induced T-cell 
activation and the monocyte structure recognized by K20 is directly 
required for this activation. K20 is assigned to the CDw29 cluster of 
differentiation antigens with the MoAb 4B4 which defines the 
human helper inducer subset of lymphocytes (321. The importance 
of the skin as a functional unit of the immune system has already 
been pointed out. The epidermis produces factors that are crucial to 
T-lymphocyte functions. These include an epidermal thymocyte- 
activating factor [33] and a thymopoietin-like molecule [34]. In 
addition, epidermal keratinocytes can induce T-cell differentiation 
[35] and LC are known as antigen- resenting epidermal cells. Thus, 
the concept that the antigens de R ned by K20 on LC and BC are 
“recognition” molecules that may play a role in the homing of 
lymphocytes to the epidermis cannot be ruled out. 
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